Influence of fingolimod on basic lymphocyte subsets frequencies in the peripheral blood of multiple sclerosis patients – preliminary study

BACKGROUND: Fingolimod is a drug administered orally to adult patients treated for relapsing remitting course of multiple sclerosis (MS). Mode of action of fingolimod is based on intense S1P1 receptor stimulation and “arresting” lymphocytes in lymphatic organs. Objective of the research was to asses...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cent Eur J Immunol
Autores principales: Rudnicka, Julia, Czerwiec, Michał, Grywalska, Ewelina, Siwicka-Gieroba, Dorota, Walankiewicz, Monika, Grafka, Agnieszka, Zgurski, Michał, Surdacka, Agata, Bartosik-Psujek, Halina, Roliński, Jacek
Formato: Artigo
Lenguaje:Inglês
Publicado: Polish Society of Experimental and Clinical Immunology 2015
Materias:
Original Paper
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4655387/
https://ncbi.nlm.nih.gov/pubmed/26648781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ceji.2015.54599
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares